Discard the Curative Causes of Late Onset Epilepsy: the Role of Brain 18F-FDG PET

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05831371

Acronym

EPITEP

Enrollment

Registered

2023-04-26

Start date

2023-05-02

Completion date

2023-09-02

Last updated

2023-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Late Onset Epilepsy

Keywords

FDG PET, cognitive prognosis

Brief summary

Etiology and cognitive prognosis in late onset epilepsy differ from young adults epilepsy. At the epilepsy onset, this is crucial to detect potential curative/treatable brain disorders. After classical investigation including morphological brain imaging, EEG, clinical assessment, which added value may have brain FDG PET in the diagnosis and prognosis evaluation?

Interventions

DIAGNOSTIC_TESTTEP FDG

FDG TEP peformed in clinical routine

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

60 Years to No maximum

Healthy volunteers

Inclusion criteria

* late onset épilepsy patients without lesion * epilepsy followed at the CHRU Nancy france

Exclusion criteria

* epilepsy explained by cortical lesion * severe psychiatric disorders * severe addiction (alcool, drugs) * no FDG TEP performed * no neuropsychological assessement after 2 years epilepsy onset

Design outcomes

Primary

Measure	Time frame	Description
diagnostic performances	2 years after epilepsy onset	sensibility, specificty, accurracy

Secondary

Measure	Time frame	Description
cognitive prognosis performances	2 years after epilepsy onset	sensibility, specificty, accurracy

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026